DOXORUBISIN HYDROCHLORIDE
Ruxodox

RUXODOX is indicated, often in combination with other antineoplastic agents, for the treatment of Hodgkin’s disease, non-Hodgkin’s lymphomas, acute leukemias, bone and soft-tissue sarcomas, neuroblastoma, Wilms’ tumour, and malignant neoplasms of the bladder, breast, lungs, ovary, and stomach, and has also been used in the treatment of other tumors.

Packaging: Single vial
Shelf Life: 24 months
Origin: India
Dosage Form: Solution for IV Infusion